RATIONALE: Mitochondria have important roles in intracellular energy generation, modulation of apoptosis, and redox-dependent intracellular signaling. Although reactive oxygen species (ROS) participate in the regulation of intracellular signaling pathways, including activation of nuclear factor (NF)-kappaB, there is only limited information concerning the role of mitochondrially derived ROS in modulating cellular activation and tissue injury associated with acute inflammatory processes. OBJECTIVES: To examine involvement of the mitochondrial electron transport chain complex I on LPS-mediated NF-kappaB activation in neutrophils and neutrophil-dependent acute lung injury. METHODS: Neutrophils incubated with rotenone or metformin were treated with bacterial lipopolysaccharide (LPS) to determine the effects of mitochondrial complex I inhibition on intracellular concentrations of reactive oxygen species, NF-kappaB activation, and proinflammatory cytokine expression. Acute lung injury was produced by intratracheal injection of LPS into control, metformin, or rotenone-treated mice. MEASUREMENTS AND MAIN RESULTS: Inhibition of complex I with either rotenone or the antihyperglycemic agent metformin was associated with increased intracellular levels of both superoxide and hydrogen peroxide, as well as inhibition of LPS-induced I kappaB-alpha degradation, NF-kappaB nuclear accumulation, and proinflammatory cytokine production. Treatment of LPS-exposed mice with rotenone or metformin resulted in inhibition of complex I in the lungs, as well as diminished severity of lung injury. CONCLUSIONS: These results demonstrate that mitochondrial complex I plays an important role in modulating Toll-like receptor 4-mediated neutrophil activation and suggest that metformin, as well as other agents that inhibit mitochondrial complex I, may be useful in the prevention or treatment of acute inflammatory processes in which activated neutrophils play a major role, such as acute lung injury.
RATIONALE: Mitochondria have important roles in intracellular energy generation, modulation of apoptosis, and redox-dependent intracellular signaling. Although reactive oxygen species (ROS) participate in the regulation of intracellular signaling pathways, including activation of nuclear factor (NF)-kappaB, there is only limited information concerning the role of mitochondrially derived ROS in modulating cellular activation and tissue injury associated with acute inflammatory processes. OBJECTIVES: To examine involvement of the mitochondrial electron transport chain complex I on LPS-mediated NF-kappaB activation in neutrophils and neutrophil-dependent acute lung injury. METHODS: Neutrophils incubated with rotenone or metformin were treated with bacterial lipopolysaccharide (LPS) to determine the effects of mitochondrial complex I inhibition on intracellular concentrations of reactive oxygen species, NF-kappaB activation, and proinflammatory cytokine expression. Acute lung injury was produced by intratracheal injection of LPS into control, metformin, or rotenone-treated mice. MEASUREMENTS AND MAIN RESULTS: Inhibition of complex I with either rotenone or the antihyperglycemic agent metformin was associated with increased intracellular levels of both superoxide and hydrogen peroxide, as well as inhibition of LPS-induced I kappaB-alpha degradation, NF-kappaB nuclear accumulation, and proinflammatory cytokine production. Treatment of LPS-exposed mice with rotenone or metformin resulted in inhibition of complex I in the lungs, as well as diminished severity of lung injury. CONCLUSIONS: These results demonstrate that mitochondrial complex I plays an important role in modulating Toll-like receptor 4-mediated neutrophil activation and suggest that metformin, as well as other agents that inhibit mitochondrial complex I, may be useful in the prevention or treatment of acute inflammatory processes in which activated neutrophils play a major role, such as acute lung injury.
Authors: Jaroslaw W Zmijewski; Sami Banerjee; Hongbeom Bae; Arnaud Friggeri; Eduardo R Lazarowski; Edward Abraham Journal: J Biol Chem Date: 2010-08-20 Impact factor: 5.157
Authors: Hong-Beom Bae; Jaroslaw W Zmijewski; Jessy S Deshane; Degui Zhi; Lawrence C Thompson; Cynthia B Peterson; David D Chaplin; Edward Abraham Journal: Am J Respir Cell Mol Biol Date: 2012-01-26 Impact factor: 6.914
Authors: Jean-Marc Tadié; Hong-Beom Bae; Sami Banerjee; Jaroslaw W Zmijewski; Edward Abraham Journal: Am J Physiol Cell Physiol Date: 2011-10-19 Impact factor: 4.249
Authors: Hong-Beom Bae; Jaroslaw W Zmijewski; Jessy S Deshane; Jean-Marc Tadie; David D Chaplin; Seiji Takashima; Edward Abraham Journal: FASEB J Date: 2011-09-01 Impact factor: 5.191
Authors: Ming-Yuan Jian; Mikhail F Alexeyev; Paul E Wolkowicz; Jaroslaw W Zmijewski; Judy R Creighton Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-10-04 Impact factor: 5.464
Authors: Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski Journal: Mol Med Date: 2013-11-08 Impact factor: 6.354
Authors: Sami Banerjee; Jaroslaw W Zmijewski; Emmanuel Lorne; Gang Liu; Yonggang Sha; Edward Abraham Journal: J Biol Chem Date: 2009-11-20 Impact factor: 5.157